B-Vitamins and Fatty Acids in the Prevention and Treatment of Alzheimer's Disease and Dementia: A Systematic Review
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The increasing worldwide prevalence of dementia is a major public health concern. Findings from some epidemiological studies suggest that diet and nutrition may be important modifiable risk factors for development of dementia. In order to evaluate the strength of the available evidence of an association of dietary factors with dementia including Alzheimer's disease (AD), we systematically searched relevant publication databases and hand-searched bibliographies up to end July 2007. We included prospective cohort studies which evaluated the association of nutrient levels with the risk of developing dementia and randomized intervention studies examining the treatment effect of nutrient supplementation on cognitive function. One hundred and sixty studies, comprising ninety one prospective cohort studies and sixty nine intervention studies, met the pre-specified inclusion criteria. Of these, thirty-three studies (19 cohort and 14 randomized controlled trials) investigated the effects of folate, B-vitamins, and levels of homocysteine (a biomarker modifiable through B-vitamin supplementation) or fish/fatty acids and are the focus of the present report. Some observational cohort studies indicated that higher dietary intake or elevated serum levels of folate and fish/fatty acids and low serum levels of homocysteine were associated with a reduced risk of incident AD and dementia, while other studies reported no association. The results of intervention studies examining the effects of folic acid or fatty acid supplementation on cognitive function are inconsistent. In summary, the available evidence is insufficient to draw definitive conclusions on the association of B vitamins and fatty acids with cognitive decline or dementia, and further long-term trials are required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions
Higgins, J. P. T., Green, S., & Ben Van Den, A. (2020) · International Coaching Psychology Review · doi:10.53841/bpsicpr.2020.15.2.123 · Cited by 5,670
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237 · cited 5×
“Homocysteine Five cohort studies (Table 1) reported data on the relationship between levels of serum homocysteine and development of incident dementia and/or AD [26,28, 29,33,35].”
InfluentialAn active and socially integrated lifestyle in late life might protect against dementia
Fratiglioni, L., Paillard-Borg, S., & Winblad, B. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00767-7 · Cited by 2,135
Principles Of Nutritional Assessment
Gibson, R. S. (2005) · doi:10.1093/oso/9780195171693.001.0001 · Cited by 1,887
Mann, C. J. (2003) · Emergency Medicine Journal · doi:10.1136/emj.20.1.54 · Cited by 1,558 · cited 1×
“Cross sectional studies only measure association not causation [20].”
Recall bias in epidemiologic studies
Coughlin, S. S. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90060-3 · Cited by 1,381
Consumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease
Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., Aggarwal, N., & Schneider, J. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.940 · Cited by 1,135 · cited 1×
“One study reported a marginal reduced risk of dementia and AD with increased fish consumption [42], and a second study reported a reduced risk of AD with increased total n-3 fatty acids, DHA and fish consumption [40].”
Durga, J., van Boxtel, M. P., Schouten, E. G., Kok, F. J., Jolles, J., Katan, M. B., & Verhoef, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60109-3 · Cited by 758 · cited 4×
“Four RCTs (Table 2) investigated the effect of folic acid supplementation alone, on cognitive function [45, 46,48,52].”
InfluentialFreund-Levi, Y., Eriksdotter-Jönhagen, M., Cederholm, T., Basun, H., Faxén-Irving, G., Garlind, A., Vedin, I., Vessby, B., Wahlund, L.-O., & Palmblad, J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1402 · Cited by 751
Schaefer, E. J., Bongard, V., Beiser, A. S., Lamon-Fava, S., Robins, S. J., Au, R., Tucker, K. L., Kyle, D. J., Wilson, P. W. F., & Wolf, P. A. (2006) · Archives of Neurology · doi:10.1001/archneur.63.11.1545 · Cited by 686 · cited 10×
“Fish and fatty acids Eight cohort studies (Table 3) examined the effects of n-3 fatty acids on the incidence of dementia and AD [37,38,49,40–44], seven of which assessed dietary intake of fish and/or general PUFAs [37,39–44], one study also assessed serum concentrations of DHA [41] and a final study reported only seru…”
InfluentialHomocysteine and folate as risk factors for dementia and Alzheimer disease
Ravaglia, G., Forti, P., Maioli, F., Martelli, M., Servadei, L., Brunetti, N., Porcellini, E., & Licastro, F. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.3.636 · Cited by 500
Lawlor, D. A., Smith, G. D., Bruckdorfer, K. R., Kundu, D., & Ebrahim, S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16260-0 · Cited by 438
Relation of cognitive activity to risk of developing Alzheimer disease
Wilson, R. S., Scherr, P. A., Schneider, J. A., Tang, Y., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271087.67782.cb · Cited by 400 · cited 6×
“L au ri n, 20 03 [3 8] 5 M al es an d fe m al es > 65 y (m ea n: 76 .”
InfluentialFotuhi, M., Mohassel, P., & Yaffe, K. (2009) · Nature Reviews Neurology · doi:10.1038/ncpneuro1044 · Cited by 344
Diet and risk of dementia: Does fat matter?: The Rotterdam Study
Engelhart, M. J., Geerlings, M. I., Ruitenberg, A., van Swieten, J. C., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2002) · Neurology · doi:10.1212/01.wnl.0000038345.77753.46 · Cited by 324
Physical activity in relation to cognitive decline in elderly men: The FINE Study
van Gelder, B. M., Tijhuis, M. A. R., Kalmijn, S., Giampaoli, S., Nissinen, A., & Kromhout, D. (2004) · Neurology · doi:10.1212/01.wnl.0000147474.29994.35 · Cited by 311 · cited 6×
“E us se n, 20 06 [4 7] M al es an d fe m al es > 70 y (m ea n: 82 ) C om m un ity an d In st itu tio na ldw el lin g”
InfluentialDangour, A. D., Allen, E., Elbourne, D., Fasey, N., Fletcher, A. E., Hardy, P., Holder, G. E., Knight, R., Letley, L., Richards, M., et al. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.29121 · Cited by 296
Self-citationJama, J. W., Launer, L. J., Witteman, J. C. M., den Breeijen, J. H., Breteler, M. M. B., Grobbee, D. E., & Hofman, A. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008922 · Cited by 252
Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk
Devore, E. E., Grodstein, F., van Rooij, F. J., Hofman, A., Rosner, B., Stampfer, M. J., Witteman, J. C., & Breteler, M. M. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27037 · Cited by 205
Plasma homocysteine levels and risk of Alzheimer disease
Luchsinger, J. A., Tang, M. X., Shea, S., Miller, J., Green, R., & Mayeux, R. (2004) · Neurology · doi:10.1212/01.wnl.0000129504.60409.88 · Cited by 171 · cited 1×
“Homocysteine Five cohort studies (Table 1) reported data on the relationship between levels of serum homocysteine and development of incident dementia and/or AD [26,28, 29,33,35].”
Mooijaart, S. P., Gussekloo, J., Frölich, M., Jolles, J., Stott, D. J., Westendorp, R. G., & de Craen, A. J. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.4.866 · Cited by 159
Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging
Kröger, E., Verreault, R., Carmichael, P.-H., Lindsay, J., Julien, P., Dewailly, É., Ayotte, P., & Laurin, D. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26987 · Cited by 149 · cited 1×
“These findings have been confirmed in three recently published cohort studies [74–76], only one of which reported that higher plasma n-3 PUFA proportions predicted less decline in speed-related cognitive domains over three years follow-up [76].”
n−3 Fatty acid proportions in plasma and cognitive performance in older adults
Dullemeijer, C., Durga, J., Brouwer, I. A., van de Rest, O., Kok, F. J., Brummer, R.-J. M., van Boxtel, M. P., & Verhoef, P. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1479 · Cited by 148
Homocysteine and Cognitive Performance in the Framingham Offspring Study: Age Is Important
Elias, M. F., Sullivan, L. M., D'Agostino, R. B., Elias, P. K., Jacques, P. F., Selhub, J., Seshadri, S., Au, R., Beiser, A., & Wolf, P. A. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi259 · Cited by 136
Fioravanti, M., Ferrario, E., Massaia, M., Cappa, G., Rivolta, G., Grossi, E., & Buckley, A. E. (1997) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(97)00028-9 · Cited by 115 · cited 3×
“Four RCTs (Table 2) investigated the effect of folic acid supplementation alone, on cognitive function [45, 46,48,52].”
Vitamin E levels, cognitive impairment and dementia in older persons: the InCHIANTI study
Cherubini, A., Martin, A., Andres-Lacueva, C., Di Iorio, A., Lamponi, M., Mecocci, P., Bartali, B., Corsi, A., Senin, U., & Ferrucci, L. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.002 · Cited by 94
Mendelsohn, A. B., Belle, S. H., Stoehr, G. P., & Ganguli, M. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009556 · Cited by 88
Pathansali, R., Mangoni, A. A., Creagh-Brown, B., Lan, Z.-C., Ngow, G.-L., Yuan, X.-F., Ouldred, E. L., Sherwood, R. A., Swift, C. G., & Jackson, S. H. D. (2006) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2005.10.002 · Cited by 41
Serum α-tocopherol, concurrent and past vitamin E intake, and mild cognitive impairment
Dunn, J. E., Weintraub, S., Stoddard, A. M., & Banks, S. (2007) · Neurology · doi:10.1212/01.wnl.0000255940.13116.86 · Cited by 25
Cited by
B Vitamins and the Brain: Mechanisms, Dose and Efficacy—A Review
Kennedy, D. (2016) · Nutrients · doi:10.3390/nu8020068 · Cited by 1,055
“Indeed, reviews and meta-analyses published over more than a decade have provided scant evidence to support this hypothesis [122–127].”
Hersi, M., Irvine, B., Gupta, P., Gomes, J., Birkett, N., & Krewski, D. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.03.006 · Cited by 332
Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Consensus Conference
Morley, J. E., Morris, J. C., Berg-Weger, M., Borson, S., Carpenter, B. D., del Campo, N., Dubois, B., Fargo, K., Fitten, L. J., Flaherty, J. H., et al. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.06.017 · Cited by 328
Self-citationPlasma nutrient status of patients with Alzheimer's disease: Systematic review and meta‐analysis
Lopes da Silva, S., Vellas, B., Elemans, S., Luchsinger, J., Kamphuis, P., Yaffe, K., Sijben, J., Groenendijk, M., & Stijnen, T. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.05.1771 · Cited by 311
Self-citationButler, M., Nelson, V. A., Davila, H., Ratner, E., Fink, H. A., Hemmy, L. S., McCarten, J. R., Barclay, T. R., Brasure, M., & Kane, R. L. (2018) · Annals of Internal Medicine · doi:10.7326/m17-1530 · Cited by 144
Metadata
- Authors
- Dangour, A. D., Whitehouse, P. J., Rafferty, K., Mitchell, S. A., Smith, L., Hawkesworth, S., & Vellas, B.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2010-09-28
- Volume
- 22
- Issue
- 1
- Pages
- 205-224
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W177216928
- Cited by
- 123
- References
- 29
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.